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ABSTRACT 
Aim. To analyze whether PPM affects QOL and functional status in patients after isolated AVR for aortic 
stenosis (AS) with preserved left ventricular ejection fraction (LVEF). 
Methods. Consecutive patients who underwent AVR in University Hospital Center Zagreb for isolated 
severe symptomatic AS and preserved EF were enrolled. Echo data was obtained from complete 
transthoracic examinations prior and after surgery by offline analysis. Patients were divided into two 
groups according to presence of PPM (effective orifice area (EOA)/body surface area (BSA) 
<0,85cm2/m2). QOL was assessed by telephone interview using Short Form 36-Item Health Survey (SF-
36) along with functional NYHA status estimation. 
Results. A total of 45 pts were included (23 female), and divided in PPM (n=26), and non PPM group 
(n=19). Both groups were similar in pts age, LVEF, AVA/BSA prior surgery. After surgery, 57% of pts 
had PPM categorized as mild PPM. During follow up of 2,5 years, 3 pts had died and 10 were lost from 
following. There was no difference in NYHA status after surgery between groups (p=0,758). SF36 results 
showed no difference between groups. However, there was a significant improvement in Physical 
functioning (47,50% vs 75,47%,p=0,000) and Role limitation due to physical health (41,41% vs 
81,25%,p=0,007) scores in the whole study population after AVR. Males had significantly better 
Energy/fatigue (p=0,034), Social functioning (p=0,004) and Pain (p=0,017) scores. 
Conclusions. Mild to moderate PPM showed no clinical relevance. All patients revealed improvement in 
QOL after AVR, while male sex was related to better functioning scores irrespectively of PPM. 
 
 
  
 
 
 
 INTRODUCTION 
Since it was first described by Rahimtoola in 1978, (1), patient prosthesis mismatch (PPM) has caused a 
lot of controversies. It means that the effective orifice area (EOA) of the implanted valve is too small for 
the patient's body surface area (BSA). PPM is more common in patients with large BSA, but it also 
depends on the left ventricular outflow tract (LVOT) diameter (2-4). In patients with aortic stenosis, due 
to left ventricular hypertrophy and excessive calcifications, LVOT diameter gradually gets smaller and 
precludes implantation of the prosthetic valve of appropriate size (4).  
PPM is generally a relatively common finding, found in up to 70% AVR procedures (2,5-8). If the 
EOA/BSA ratio is <0,85cm2/m2, PPM is defined as mild or moderate, and as severe if the EOA/BSA 
ratio is <0,65cm2/m2 (2). Patient outcomes mainly depend on the severity of PPM. Severe PPM has been 
shown to have worse long term survival, lower cardiac-related-death survival and lower left ventricular 
(LV) mass reduction (9). 
However, the impact of patient prosthesis mismatch on the outcomes remains unresolved. In some 
studies, PPM did impact long term survival and cardiac related deaths (9-11) whereas in other there was 
no significant difference comparing to no PPM patients (8,11-12). Studies are more uniform regarding 
functional capacity, with no difference comparing to no PPM patients, especially in the elderly (5,7,12-
16). 
In younger, middle-aged patients, the impact of PPM on functional capacity and QOL remains unclear. 
Higher gradients and less positive remodeling of the left ventricle may have some impact on their 
functional capacity and the risk for reoperation (8). The aim of the study was to investigate the impact of 
PPM on survival, quality of life and functional status in general population with preserved ejection 
fraction after isolated AVR.  
 
METHODS 
A retrospective observational study was conducted in the University Hospital Center Zagreb. Patients’ 
demographic data and data regarding cardiac surgery were acquired from the hospital digital database and 
medical charts. Offline analysis of the previously recorded and digitally stored transthoracic 
echocardiographic exams was performed on the echo workstations using GE EchoPac software. Data 
concerning the quality of life and functional status were collected in December 2015 via telephone 
medical interview. Oral informed consent was obtained from each patient.   
Patients 
Consecutive patients with preserved ejection fraction (LVEF > 45%) and severe symptomatic aortic 
stenosis who underwent isolated AVR in our institution, in the period from 2010-2014, were enrolled. 
Patients with reduced ejection fraction and concomitant coronary artery disease or other valvular disease 
regarding intervention, those with poor acoustic echo window and no preoperative TTE, were excluded 
from the study. Patient inclusion and exclusion criteria were met accordingly to medical charts data. Also, 
patients with poor acoustic echo window on echo data prior to surgery were excluded from the study.  
Echocardiography 
We have retrospectively analyzed the digitally stored echocardiographic data - a complete standard 
transthoracic echocardiographic study was preformed prior to surgery and in the early postoperative 
period.  
Prior to surgery, the following echo parameters were analyzed: LVEF, global longitudinal strain (GLS), 
maximal and mean gradients over aortic valve and aortic valve area (AVA). The left ventricular ejection 
fraction was calculated using Simpson Biplane method and the global longitudinal strain (GLS) was 
measured using 2D speckle tracking. The aortic valve area was calculated using the continuity equation 
and indexed for body surface area (BSA).  
After AVR, the same methods were used for the quantification of the LVEF and measurement of GLS, 
maximum and mean pressure gradients. The effective orifice valve area values were taken from the 
manufacturer’s data. PPM was then calculated from the expected effective orifice area (EOA) for each 
valve type and size, and indexed by patient's body surface area (BSA).  
Patient prosthesis mismatch 
According to the calculated EOA/BSA after operation, patients were divided into two groups based on 
PPM presence. If EOA/BSA was < 0,85cm2/m2, the patient was classified into PPM group.  
Quality of life survey 
QOL was assessed in December 2015 by telephone interview using the Short Form 36-Item Health 
Survey (SF-36) questionnaire. The doctor performing the interview has read the questions exactly as 
written and recorded answers in numeric form. Patients were also asked additional questions in order to 
estimate their functional status according to the New York Heart Association (NYHA) classification. The 
results were recorded in numerical form (I-IV). Questions were also asked about additional data regarding 
mortality and hospitalizations due to heart failure.  
Standard analysis of the SF-36 questionnaire was done, using the following scores calculated from the 
questionnaire: Physical functioning (PF), Role limitations due to physical health (RLPH), Role limitations 
due to emotional problems (RLEH), Energy/fatigue (EF), Emotional well-being (EMWB), Social 
functioning (SF), Pain (P) and General health (GH). 
Statistical analysis 
Descriptive statistics was done to analyze population characteristics, ECHO parameters and QOL data. 
When comparing the two populations adequate tests depending on variable type and data distribution 
were used (chi-square, Mann-Whitney, t-test, ANOVA). Statistical analysis was done using SPSS v21 
IBM software. 
RESULTS 
A total of 45 patients (23 female, 22 male), aged 67,4±10,7 years were included in the study. All patients 
had a preserved LVEF (57,3±8,05%). They all had an isolated severe aortic stenosis (0,65±0,2cm2). After 
AVR, 18 mechanical (40%) and 27 biological valves (60%) were implanted. Postoperative EOA/BSA 
was calculated and patients were divided into two groups:  PPM group (n=26), and no PPM group (n=19). 
Mean EOA/BSA in no PPM group was 1,0068cm2/m2. There were in total 57% patients with PPM 
(mean EOA/BSA 0,76±0,05cm2/m2, p=0,000 ), categorized as mild to moderate PPM. Further subgroup 
analysis for moderate and severe PPM was not performed due to the small number of patients. 
There was no significant difference in demographic parameters or in basic echocardiographic parameters 
prior to surgery between groups. Mean age of patients in no PPM group was 66,61±11,07 years and in 
PPM group 62,5±18,25 years, p=0,472; body surface area was 1,86cm2/m and 1,95m2 respectively, 
p=0,215. All patients had a preserved left ventricular ejection fraction (LVEF) prior surgery: 
59,68±6,07% (no-PPM group) vs 55,58±8,95% (PPM group), p=0,091. Global longitudinal strain (GLS) 
was reduced in both groups: -15,080% vs -11,827%, p=0.363. Calculated aortic valve area was 0,70±0,20 
cm2, indexed 0,36±0,09 cm2/m2 in no-PPM group and 0,61±0,19 cm2, indexed 0,31±0,09cm2/m2 in 
PPM group (p=0,156; p=0,065 respectively). 
Mechanical valves were implanted in 42% of no-PPM group and 38% of PPM group, and biological in 
58% and 62% respectively (p=0,805). The postoperative transthoracic echocardiography was preformed 
within 6,79 days in no PPM and 8,04 days in PPM group (p=0,517). In this early postoperative period, we 
found no significant difference in LV function, although a trend toward higher values was present among 
patients in no-PPM group: LVEF: 60,63% vs 58,53% (p=0,261), GLS -14,75% vs -12,08% (p=0,428). 
Maximum and mean pressure gradient (PG) across implanted valve also showed no difference between 
the patient groups (38 vs 45 mmHg maxPG, p=0,149; 20 vs 25 mmHg meanPG, p=0,096). 
The mean follow up period was 32,95±12,12 months in no-PPM and 31,23±10,97 months in PPM group 
(p=0,683). During this period, 3 patients had died (1 in no PPM and 2 in PPM group) and 10 pts were lost 
from following. In total, 32 of 45 patients (71,1%) were interviewed (13/19, 68,4% no PPM; 19/26, 
73,1% PPM). No difference in functional NYHA status between groups was found (p=0,758): all patients 
were in NHYA status I–III. 
No significant differences between PPM groups were found in QOL SF-36 scores (Table 1). However, 
when compared to preoperative scores, a significant improvement in Physical functioning score (PF, 
p=0,000) and Role limitation due to physical health score (RLPH, p=0,007) was found in the whole study 
population, showed in table 2. 
After subgroup analysis regarding sex category, males and females were matched in demographic and 
echocardiographic parameters as well as in PPM incidence. Interestingly when analyzing QOL, it was 
found that men had a significantly better Energy/fatigue (EFS, p=0,034), Social functioning (SF, 
p=0,004) and Pain (P, p=0,017) scores (table 3). 
DISCUSSION     
Patient prosthesis mismatch represents hemodynamic abnormality due to the inadequate artificial valve 
size according to the patient BSA (1,2). Ideally, taking into account patients BSA, a prosthesis with 
EOA/BSA > 0,85cm2/m2 should be implanted. In patients with isolated aortic stenosis, a large amount of 
calcification and also interventricular septum hypertrophy due to chronic pressure overload is present (4). 
These cause the LVOT narrowing and make impossible to implant adequate–sized prosthesis without 
preforming the LVOT dilation procedures, which significantly prolong surgery and increase operative 
risk. 
PPM is a common finding after AVR. It is mostly mild to moderate, with incidence ranging in studies 
from 20% to 70%, while severe PPM is rare (2%-11% in studies) (2,5-8). In our study, 57% pts had PPM, 
categorized as mild to moderate. 
There is a lot of debate in literature about patient prosthesis mismatch concerning outcomes and LV 
reverse remodeling (9-11). In general, mild to moderate PPM did not show in previous studies impact on 
survival (9-10). Our results also did not show a significant difference in mortality or hospitalization rate 
due to heart failure in PPM group , which is in accordance with previous studies.  
However, some smaller studies have found difference in functional status and the quality of life in elderly, 
70-80 years old patient population (5,7,12-16). However, in these studies, patients were dispersive 
concerning the type of the procedure (isolated AVR, or AVR+CABG) and systolic LV function prior 
operation, two factors interfering with mortality rate and physical functioning. We have studied the 
impact of PPM in general, younger population. It is expected that this group of patients have a more 
active life style than octogenarians and less symptoms. The patients with reduced LVEF or coronary 
artery disease were excluded from the study, and a homogenous population that underwent isolated AVR 
for severe AS and had preserved ejection fraction prior operation was analyzed, so that any difference in 
QOL or functional status would be more specific for PPM influence.  
Prior AVR, there were no significant differences between groups in demographic parameters, gender, 
severity of aortic stenosis or LV function. In the early postoperative period, echocardiography revealed a 
trend to better LV ejection function and GLS in both groups, but no statistical significance was reached. 
The average mean gradient was found to be higher in PPM group (24,85 mmHg vs 20,05 mmHg in no 
PPM), which is in concordance with previous studies (17). This difference is important because, during 
exercise, the mean gradient is increasing, getting close to values measured in mild to moderate native 
aortic stenosis, while in patients without mismatch mean gradients remain normal (3,18). These higher 
gradients in high flow rate state could cause difference in functional capacity and impact QOL in more 
active patients.  
In our study, after AVR, all patients had relief of symptoms with significant improvement of functional 
status and QOL in the late follow up of about 2,5years. The most prominent improvement was noticed in 
„Physical functioning“ and „Role limitation due to physical health“ after AVR in the whole population 
(table 2). These are the scores that are the most related to functional status and physical activity. But, 
there was no significant difference between PPM groups in these scores (table 1). This means that 
pressure unloading is significant enough to decrease symptoms, even if some degree of hemodynamic 
obstruction is still present. These findings are similar like those in previous studies with elderly patients 
(5,7,12-13,15-16), even though elderly patients have less demanding life style.  
Gender subgroup analysis showed significant differences between males and females in Energy/Fatigue 
and Social functioning scores (table 3). This is probably more related to psychological aspect concerning 
surgery, social functioning and self-esteem, which needs a further investigation. It is important to notice 
that there was no difference in genders relating to physical functioning and functional status. 
Limitations of the study 
The main limitation of the study was the small study population. It would be interesting to analyze, on a 
bigger sample, the difference between mild and severe PPM as well as differences between mechanical 
and biological prostheses.  
CONCLUSION 
Our results have shown that a mild to moderate PPM in patients with preserved ejection fraction 
undergoing isolated AVR, has no influence on survival, functional capacity and QOL. According to this, 
the patient’s cardiologist and surgeon should decide on preforming higher risk surgery procedures only to 
avoid severe PPM, irrespective of age.  
 
 
Table 1. Quality of life scores in patients with 
and without patient prosthesis mismatch after 
aortic valve replacement.  
 PPM N Mean SD Sig. 
PF 
No-PPM 13 72,31 28,18 
0,564 
PPM 19 77,63 23,23 
RLPH 
No-PPM 13 82,69 31,26 
0,850 
PPM 19 80,26 37,80 
RLEH 
No-PPM 13 94,87 12,52 
0,985 
PPM 19 94,74 22,94 
EF 
No-PPM 13 59,23 4,00 
0,478 
PPM 19 57,37 10,18 
EMWB 
No-PPM 13 75,39 2,21 
0,113 
PPM 19 71,79 9,08 
SF 
No-PPM 13 69,23 18,12 
0,505 
PPM 19 64,47 20,52 
P 
No-PPM 13 77,12 17,17 
0,915 
PPM 19 76,32 22,54 
GH 
No-PPM 13 63,08 15,08 
0,666 
PPM 19 60,00 24,78 
PPM=patient prosthesis mismatch, PF=Physical functioning, RLPH=Role limitations due to physical health, RLEH=Role 
limitations due to emotional problems, EF=Energy/fatigue, EMWB=Emotional well-being, SF=Social functioning, P=Pain, 
GH=General health 
  
 
Table 2. Postoperative improvement in quality of 
life scores in the whole study population 
 
 
Mean N SD Sig. 
PF preAVR 
PF postAVR 
47,50 32 24,56 
0,000 
75,46 32 25,05 
RLPH preAVR 
RLPH postAVR 
41,40 32 45,61 
0,000 
81,25 32 34,78 
 
AVR=aortic valve replacement, PF=Physical functioning, RLPH=Role limitations due to physical health 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Gender differences in quality of life scores after aortic valve replacement 
 
 
Sex N Mean SD Sig. 
PF 
F 16 71,56 22,41 
0,387 
M 16 79,38 27,62 
RLPH 
F 16 70,31 40,02 
0,076 
M 16 92,19 25,36 
RLEH 
F 16 89,58 26,44 
0,136 
M 16 100,00 0,00 
EF 
F 16 55,00 10,33 
0,034 
M 16 61,25 3,42 
EMWB 
F 16 71,00 9,74 
0,089 
M 16 75,50 2,00 
SF 
F 16 57,03 18,24 
0,004 
M 16 75,78 16,12 
P 
F 16 68,28 22,34 
0,017 
M 16 85,00 14,05 
GH 
F 16 54,38 25,03 
0,067 
M 16 68,13 14,01 
 
M=male, F=female; PF=Physical functioning, RLPH=Role limitations due to physical health, RLEH=Role limitations due to 
emotional problems, EF=Energy/fatigue, EMWB=Emotional well-being, SF=Social functioning, P=Pain, GH=General health. 
 
 
 
 
 
 
 
 
 
 
 
 
References: 
[1] Rahimtoola S H. The problem of valve prosthesis‐patient mismatch. Circulation 19785820–24.24 
[2] Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. 
Heart. 2006, 92: 1022-1029. 10.1136/hrt.2005.067363. 
[3] Pibarot P, Dumesnil JG, MD. Hemodynamic and clinical impact of prosthesis–patient mismatch in the 
aortic valve position and its prevention. J Am Coll Cardiol. 2000;36(4):1131-1141 
[4] Pantely G, Morton M, Rahimtoola S.H. Effects of successful, uncomplicated valve replacement on 
ventricular hypertrophy, volume, and performance in aortic stenosis and in aortic incompetence. J Thorac 
Cardiovasc Surg. 75 1978:383-391 
[5] Hernandez-Vaquero D, Calvo D, Garcia JM, et alt. Influence of Patient-Prosthesis Mismatch in the 
Octogenarian Undergoing Surgery for Aortic Valve Replacement Due to Severe Stenosis. Rev Esp 
Cardiol.2011;64(9):774–779.  
[6] Head SJ, Mokhles MM, Ruben Osnabrugge RLJ et alt. The impact of prosthesis–patient mismatch on 
long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 
observational studies comprising 27 186 patients with 133 141 patient-years. European Heart Journal 
(2012)33, 1518–1529 
[7] Sportelli E, Regesta T, Salsano A, et alt. Does patient-prosthesis mismatch after aortic valve 
replacement affect survival and quality of life in elderly patients? J Cardiovasc Med (Hagerstown). 2016 
Feb;17(2):137-43.  
[8] Hernandez-Vaquero D, Garcia JM, Diaz R, et alt. Moderate patient-prosthesis mismatch predicts 
cardiac events and advanced functional class in young and middle-aged patients undergoing surgery due 
to severe aortic stenosis. J Card Surg. 2014 Mar;29(2):127-33.  
[9] Hong S, Yi G, Youn YN, Lee S, et alt. Effect of the prosthesis-patient mismatch on long-term clinical 
outcomes after isolated aortic valve replacement for aortic stenosis: a prospective observational study. J 
Thorac Cardiovasc Surg. 2013 Nov;146(5):1098-104.  
[10] Chen J, Lin Y, Kang B, Wang Z. Indexed effective orifice area is a significant predictor of higher 
mid- and long-term mortality rates following aortic valve replacement in patients with prosthesis-patient 
mismatch. Eur J Cardiothorac Surg. 2014 Feb;45(2):234-40. 
[11] Rao V, Jamieson WRE, Ivanov J et alt. Prosthesis-patient mismatch affects survival after aortic valve 
replacement. Circulation 2000;102(supl  III):III-5-III-9. 
[12] Concistre G, Dell’aquila A, Pansini S et alt. Aortic valve replacement with smaller prostheses in 
elderly patients: does patient prosthetic mismatch affect outcomes? J Card Surg 2013;28(4):341-7. 
[13] Qian XM, Zhong SZ. Impact of prosthesis-patient mismatch on the quality of life of elderly patients 
after aortic valve replacement. Nan Fang Yi Ke Da Xue Xue Bao. 2009 Oct;29(10):2055-8, 2063. 
[14] Koch CG, Khandwala F, Estafanous FG, et alt. Impact of Prosthesis–Patient Size on Functional 
Recovery After Aortic Valve Replacement. Circulation. 2005; 111: 3221-3229. 
[15] Concistrè G, Dell'Aquila A, Pansini S et alt. Aortic Valve Replacement with Smaller Prostheses in 
Elderly Patients: Does Patient Prosthetic Mismatch Affect Outcomes? J Card Surg 2013;28:341–347. 
[16] Moon MR, Lawton JS, Moazami N et alt. Point: prosthesis–patient mismatch   does   not   affect   
survival   for   patients greater  than  70  years  of  age  undergoing  bioprosthetic  aortic  valve  
replacement. J  Thorac  Cardiovasc Surg. 2009;137:278-83. 
[17] Pibarot  P, Dumesnil  J.G, Lemieux  M, et alt. Impact of prosthesis–patient mismatch on 
hemodynamic and symptomatic status, morbidity, and mortality after aortic valve replacement with a 
bioprosthetic heart valve. J Heart Valve Dis. 7 1998:211-218. 
[18] Burwash  I.G, Pearlman  A.S, Kraft  C.D, et alt. Flow dependence of measures of aortic stenosis 
severity during exercise. J Am Coll Cardiol. 24 1994:1342-1350. 
[19] Howell NJ, Keogh BE, Ray D. Patient-prosthesis mismatch in patients with aortic stenosis 
undergoing isolated aortic valve replacement does not affect survival. Ann Thorac Surg. 2010;89(1):60-4. 
[20] Urso S, Sadaba R, Aldamiz-Echevarria G. Is patient-prosthesis mismatch an independent risk factor 
for early and mid-term overall mortality in adult patients undergoing aortic valve replacement? Interact 
Cardiovasc Thorac Surg 2009;9(3):510-8. 
[21] Tully PJ, Aty W, Rice GD et alt. Aortic valve prosthesis-patient mismatch and long term 
outcomes:19-year single center experience. Ann Thorac Surg 2013;96(3):844-50. 
[22] Suehiro S. Valve Prosthesis-Patient Mismatch: Clinical Implications in Japanese Patients. Ann 
Thorac Cardiovasc Surg Vol.12, No.3(2006) 
[23] Koene BM, Hamad MAS, Bouma W, et alt. Impact of prosthesis-patient mismatch on early and late 
mortality after aortic valve replacement. Journal of Cardiothoracic Surgery 2013;8:96 
[24] Delgado V, Tops LF, van Bommel RJ. Strain analysis in patients with severe aortic stenosis and 
preserved left ventricular ejection fraction undergoing surgical valve replacement. Eur Heart J. 30 
2009:3037-47. 
[25] Grimaldi A, Figini F, Maisano F, et alt. Clinical outcome and quality of life in octogenarians 
following transcatheter aortic valve implantation (TAVI) for symptomatic aortic stenosis. Int J Cardiol. 
2013 Sep 20;168(1):281-6.  
[26] Reskovic Luksic V, Dosen D, Cekovic S, Separovic Hanzevacki J. Impact of the patient prosthesis 
mismatch on early recovery of the myocardial function after aortic valve replacement. Eur Heart J 
Cardiovasc Imaging Abstracts Supplement, December 2014. doi:10.1093/ehjci/jeu263 
